Process / pipelinecentral pain sensitization assessment
Central Sensitization Inventory
The Central Sensitization Inventory (CSI) is a 25-item self-report screening instrument developed by Mayer and colleagues in 2012 to identify patients with central sensitization—a condition characterized by amplification of pain signaling and hypersensitivity to sensory stimuli. The CSI captures the constellation of symptoms including widespread pain, sleep disturbance, cognitive dysfunction, and autonomic dysregulation associated with central sensitization syndromes such as fibromyalgia, chronic fatigue syndrome, and post-traumatic stress disorder.
Open in MethodMindSoonVideoSoon
Read the full method
Members only
Sign inSign in with a free account to read this section.
Sources
- Mayer, T.G., Neblett, R., Cohen, H., et al. (2012). The development and psychometric validation of the Central Sensitization Inventory. Pain Practice, 12(4), 276-285. DOI: 10.1111/j.1533-2500.2011.00493.x ↗
- Neblett, R., Cohen, H., Choi, Y., Hardin, J.W., Mayer, T.G., Gonder-Frederick, L.A., & Mayer, J.M. (2013). The Central Sensitization Inventory (CSI): Establishing clinically significant values for identifying central sensitization in an outpatient chronic pain population. Journal of Pain, 14(5), 438-445. DOI: 10.1016/j.jpain.2012.11.012 ↗
- Schilling, J.M., Koh, S.E., Tully, A.S., et al. (2018). Central sensitization phenotyping in patients with knee osteoarthritis. Clinical Journal of Pain, 34(4), 296-302. DOI: 10.1097/AJP.0000000000000555 ↗